SEARCH

SEARCH BY CITATION

References

  • Banerjee A. and Gerondakis S. (2007) Coordinating TLR-activated signaling pathways in cells of the immune system. Immunol. Cell Biol. 85, 420424.
  • Barton G. M. and Medzhitov R. (2003) Toll-like receptor signaling pathways. Science 300, 15241525.
  • Bhat N. R., Zhang P., Lee J. C. and Hogan E. L. (1998) Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J. Neurosci. 18, 16331641.
  • Bhat N. R., Feinstein D. L., Shen Q. and Bhat A. N. (2002) p38 MAPK-mediated transcriptional activation of inducible nitric-oxide synthase in glial cells. Roles of nuclear factors, nuclear factor kappa B, cAMP response element-binding protein, CCAAT/enhancer-binding protein-beta, and activating transcription factor-2. J. Biol. Chem. 277, 2958429592.
  • Bhat N. R., Shen Q. and Fan F. (2003) TAK1-mediated induction of nitric oxide synthase gene expression in glial cells. J. Neurochem. 87, 238247.
  • Brikos C. and O'Neill L. A. (2008) Signalling of toll-like receptors. Handb. Exp. Pharmacol. 183, 2150.
  • Ceci J. D., Patriotis C. P., Tsatsanis C., Makris A. M., Kovatch R., Swing D. A., Jenkins N. A., Tsichlis P. N. and Copeland N. G. (1997) Tpl-2 is an oncogenic kinase that is activated by carboxy-terminal truncation. Genes Dev. 11, 688700.
  • Chang L. and Karin M. (2001) Mammalian MAP kinase signalling cascades. Nature 410, 3740.
  • Diaz-Guerra M. J., Castrillo A., Martin-Sanz P. and Bosca L. (1999) Negative regulation by phosphatidylinositol 3-kinase of inducible nitric oxide synthase expression in macrophages. J. Immunol. 162, 61846190.
  • Dumitru C. D., Ceci J. D., Tsatsanis C. et al. (2000) TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 103, 10711083.
  • Erny K. M., Peli J., Lambert J. F., Muller V. and Diggelmann H. (1996) Involvement of the Tpl-2/cot oncogene in MMTV tumorigenesis. Oncogene 13, 20152020.
  • Gavrilyuk V., Horvath P., Weinberg G. and Feinstein D. L. (2001) A 27-bp region of the inducible nitric oxide synthase promoter regulates expression in glial cells. J. Neurochem. 78, 129140.
  • Gavrin L. K., Green N., Hu Y. et al. (2005) Inhibition of Tpl2 kinase and TNF-alpha production with 1,7-naphthyridine-3-carbonitriles: synthesis and structure-activity relationships. Bioorg. Med. Chem. Lett. 15, 52885292.
  • George D. and Salmeron A. (2009) Cot/Tpl-2 protein kinase as a target for the treatment of inflammatory disease. Curr. Top. Med. Chem. 9, 611622.
  • Hirata K., Miyashiro M., Ogawa H., Taki H., Tobe K. and Sugita T. (2010) Inhibition of tumor progression locus 2 protein kinase decreases lipopolysaccharide-induced tumor necrosis factor alpha production due to the inhibition of the tip-associated protein induction in RAW264.7 cells. Biol. Pharm. Bull. 33, 12331237.
  • Hu Y., Green N., Gavrin L. K. et al. (2006) Inhibition of Tpl2 kinase and TNFalpha production with quinoline-3-carbonitriles for the treatment of rheumatoid arthritis. Bioorg. Med. Chem. Lett. 16, 60676072.
  • Jager J., Gremeaux T., Gonzalez T. et al. (2010) Tpl2 kinase is upregulated in adipose tissue in obesity and may mediate interleukin-1beta and tumor necrosis factor-{alpha} effects on extracellular signal-regulated kinase activation and lipolysis. Diabetes 59, 6170.
  • Kawai T. and Akira S. (2007) TLR signaling. Semin. Immunol. 19, 2432.
  • Kitazawa M., Oddo S., Yamasaki T. R., Green K. N. and LaFerla F. M. (2005) Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J. Neurosci. 25, 88438853.
  • Lopez-Pelaez M., Soria-Castro I., Bosca L., Fernandez M. and Alemany S. (2011) Cot/tpl2 activity is required for TLR-induced activation of the Akt p70 S6k pathway in macrophages: Implications for NO synthase 2 expression. Eur. J. Immunol. 41, 17331741.
  • Lopez-Pelaez M., Fumagalli S., Sanz C., Herrero C., Guerra S., Fernandez M. and Alemany S. (2012) Cot/tpl2-MKK1/2-Erk1/2 controls mTORC1-mediated mRNA translation in Toll-like receptor-activated macrophages. Mol. Biol. Cell 23, 29822992.
  • Martel G., Berube J. and Rousseau S. (2013) The protein kinase TPL2 is essential for ERK1/ERK2 activation and cytokine gene expression in airway epithelial cells exposed to pathogen-associated molecular patterns (PAMPs). PLoS ONE 8, e59116.
  • Patriotis C., Makris A., Bear S. E. and Tsichlis P. N. (1993) Tumor progression locus 2 (Tpl-2) encodes a protein kinase involved in the progression of rodent T-cell lymphomas and in T-cell activation. Proc. Natl Acad. Sci. USA 90, 22512255.
  • Perugorria M. J., Murphy L. B., Fullard N., Chakraborty J. B., Vyrla D., Wilson C. L., Oakley F., Mann J. and Mann D. A. (2013) Tumor progression locus 2/Cot is required for activation of extracellular regulated kinase in liver injury and toll-like receptor-induced TIMP-1 gene transcription in hepatic stellate cells in mice. Hepatology 57, 12381249.
  • Rousseau S., Papoutsopoulou M., Symons A., Cook D., Lucocq J. M., Prescott A. R., O'Garra A., Ley S. C. and Cohen P. (2008) TPL2-mediated activation of ERK1 and ERK2 regulates the processing of pre-TNF alpha in LPS-stimulated macrophages. J. Cell Sci. 121, 149154.
  • Salmeron A., Ahmad T. B., Carlile G. W., Pappin D., Narsimhan R. P. and Ley S. C. (1996) Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase. EMBO J. 15, 817826.
  • Shen Q., Zhang R. and Bhat N. R. (2006) MAP kinase regulation of IP10/CXCL10 chemokine gene expression in microglial cells. Brain Res. 1086, 916.
  • Soria-Castro I., Krzyzanowska A., Pelaez M. L., Regadera J., Ferrer G., Montoliu L., Rodriguez-Ramos R., Fernandez M. and Alemany S. (2010) Cot/tpl2 (MAP3K8) mediates myeloperoxidase activity and hypernociception following peripheral inflammation. J. Biol. Chem. 285, 3380533815.
  • Thirumangalakudi L., Prakasam A., Zhang R., Bimonte-Nelson H., Sambamurti K., Kindy M. S. and Bhat N. R. (2008) High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice. J. Neurochem. 106, 475485.
  • Vougioukalaki M., Kanellis D. C., Gkouskou K. and Eliopoulos A. G. (2011) Tpl2 kinase signal transduction in inflammation and cancer. Cancer Lett. 304, 8089.
  • Xiao N., Eidenschenk C., Krebs P., Brandl K., Blasius A. L., Xia Y., Khovananth K., Smart N. G. and Beutler B. (2009) The Tpl2 mutation Sluggish impairs type I IFN production and increases susceptibility to group B streptococcal disease. J. Immunol. 183, 79757983.